Company Profile
Updated: 17-SEP-093 Day Blinds Inc.
Private Company, Headquarters Location
2220 E Cerritos Ave., Anaheim, CA 92806-5709, United States
(800)800-3329, (714)634-4600, (714)634-1041 fax, http://www.3dayblinds.com
Primary SIC: Miscellaneous Homefurnishings Stores, Primary NAICS: All Other Home Furnishings Stores
Description: Retail: Manufactures and installs window coverings.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Study findings from E.A. Macgregor et al provide new insights into adverse drug reactions.
Women's Health Weekly; 11/12/2009; 967 words; ...Pharmaceuticals Inc., Chadds...efficacy of a 6-day regimen of...over 1 to 3 perimenstrual...controlled double-blind parallel trial...started -2 days to +3 (Study 1...Study 2) days relative to the first day of menses...was given 2 days before anticipated...request ...
Study data from C.A.L. Gaffaney and co-authors update knowledge of women's health.(Clinical report)
Women's Health Weekly; 11/12/2009; 908 words; ...performed a randomized, double-blind, placebo-controlled study...mu g or placebo daily for 3 days unless the subject developed...of oral misoprostol over 3 days to women with prolonged pregnancies...is: Thieme Medical Publ Inc., 333 Seventh Avenue...
Hyperion Therapeutics Announces First Patient Enrolled in Pivotal Trial in Patients With Urea Cycle Disorders.(Clinical report)
Biotech Week; 11/11/2009; 1627 words; ...randomized, double-blind, cross-over study...under the curve on Days 14 and 28 (last day of each treatment...phenylbutyrate (~ 3.5 teaspoons) delivers...and Ucyclyd Pharma, Inc., a subsidiary of...Hyperion Therapeutics, Inc.). BUPHENYL is...of Ucyclyd Pharma, Inc. Full ...
Results of Phase I Study Show Novel, Investigational PA65020 Compound Significantly Decreased Risk of Upper GI Damage in Healthy Adults.
Biotech Week; 11/11/2009; 1552 words; POZEN Inc. (NASDAQ: POZN) announced...randomized, double-blind study highlighted that...science (see also POZEN Inc.). "These findings...twice daily. Following 28 days of therapy, 15% of the...treatment group had Grade 3 or 4 Lanza scores (P...these complications at day 28. No serious ...
Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia.
Clinical Trials Week; 11/9/2009; 1837 words; ...Forest Laboratories, Inc. (NYSE: FRX) and...Forest Laboratories, Inc.). For the primary...to initiate Phase 3 trials for both indications...therapy for up to seven days, a total of 732 patients...d cariprazine, 3.0 mg/d cariprazine...weeks of the double-blind treatment. ...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning